United States: FDA's Proposed Rule On LDT Regulation And The Debate Over Agency Deference - Sheppard Mullin Richter & Hampton

Earlier this month, the Food and Drug Administration ("FDA" or "the Agency") issued a highly anticipated proposed rule outlining the regulatory framework and implementation plan for Laboratory Developed Tests ("LDTs").